The Kentucky Neuroscience Institute is discovering new and advanced ways to bring findings from the researcher's lab bench to the patient's bedside through clinical trials and research grants. By combining the expertise of researchers and physicians, KNI can offer the most advanced treatments.
Patients involved in research trials for neurodegenerative diseases are also monitored and evaluated for a longer period of time in comparison to the typical 60 day study. Factors such as ease of movement, communication and overall satisfaction with life are examined from a longitudinal approach. Such studies include the first North American Phase I clinical trial for Parkinson's disease.
Morris K. Udall Centers of Excellence for Parkinson's Disease Research »
Sanders-Brown Center on Aging »
Should you participate? »